MEDICAL OUTREACH TO HOMELESS SUBSTANCE USERS IN NEW YORK CITY: PRELIMINARY RESULTS*

Size: px
Start display at page:

Download "MEDICAL OUTREACH TO HOMELESS SUBSTANCE USERS IN NEW YORK CITY: PRELIMINARY RESULTS*"

Transcription

1 SUBSTANCE USE & MISUSE Vol. 37, Nos. 8 10, pp , 2002 MIGRATION, ACCULTURATION, DISPLACEMENT MEDICAL OUTREACH TO HOMELESS SUBSTANCE USERS IN NEW YORK CITY: PRELIMINARY RESULTS* Andrew Rosenblum,Ph.D., 1,y Larry Nuttbrock,Ph.D., 1 Hunter McQuistion,M.D., 2 Steve Magura,Ph.D., 1 and Herman Joseph,Ph.D. 3 1 National Development and Research Institutes, Inc., 71 West 23rd Street, 8th floor, NY, NY Project Renewal, Inc., 200 Varick Street, New York, NY New York State Office of Alcohol and Substance Abuse Services, 55 W, 125th St., New York, NY ABSTRACT An innovative, experimental, medical out-reach initiative, using a fully-equipped mobile medical van with a staff of 2 part-time physicians, a physician assistant, a social worker, and a driver/medical aid serving the needs of 1048, mostly male, minority group, high-level, homeless New York City substance users with infectious diseases is described. The study sample (N ¼ 250) was divided into experimental S s who received Intensive case management and a control group who could choose to refer themselves to the SW. *Write up of presentation for Towards the Year 2000 Conference, Jerusalem, Israel, July, y Corresponding author. andrew.rosenblum@ndri.org DOI: /JA Copyright & 2002 by Marcel Dekker, Inc (Print); (Online)

2 1270 ROSENBLUM ET AL. Biological tests revealed high rates of cocaine use and infectious diseases. Preliminary 4-month outcomes (N ¼ 128) showed reductions in drug use, homelessness and health complaints in both groups; experimental subjects compared with controls received more Public Assistance and had fewer emergency room visits. Key Words: Homelessness; Case management; Substance use; Medical outreach INTRODUCTION Substance use is associated with serious infectious diseases, such as HIV, TB, hepatitis B and C, and syphilis. [1 3] Homeless substance users represent a special concern, since the prevalence of infectious diseases is significantly higher in this population that in the general population. [4] Furthermore, homeless substance users are likely to be disaffiliated and suspicious of established health care systems. [5] This report presents findings of an ongoing study evaluating a medical outreach initiative, using a fully-equipped mobile medical van, to homeless substance users at various sites in New York City. The van staff include two part-time physicians, a physician s assistant, a social worker, and a driver/medical aid. The specific aims of the study are to conduct a medical, drug user treatment and social needs assessment survey of homeless visitors to the medical van, and to conduct a process and outcome evaluation of the mobile medical outreach clinic with the addition of intensive case management (ICM) as an experimental enhancement. VAN POPULATION In 1997 there were 1709 client visits to the medical van. This represented 1048 persons, since some had multiple visits during this period. The four most frequent presenting complaints and diagnoses were for respiratory (42%), skin (33%), psychiatric/substance abuse (30%), and cardiovascular (24%) problems. Mean age is 40, 84% are men, and most are minority (72% African-American, 18% Hispanic). STUDY SUBJECTS A total of 250 subjects were inducted into the study. The N reported below varies due to current availability of test results. Hair assays (N ¼ 184)

3 OUTREACH TO HOMELESS SUBSTANCE USERS 1271 for cocaine and opiates, obtained for research purposes, show subjects to be 78% positive for cocaine (primarily crack-cocaine based on self reports), and 15% positive for opiates. Infectious disease rates (N ¼ 200 to 228) are 13% HIV antibody; 31% hepatitis C antibody; 47% hepatitis B (core antibody); and 12% syphilis (the syphilis result does not necessarily indicate an active case). All subjects were provided pre- and posttest HIV counseling. Subjects with positive tests results were referred back to the van for medical follow-up. Experimental subjects are seen by a social worker at the time that they are recruited for the study. The social worker provides intensive case management (ICM), which includes a comprehensive needs assessment, multiple sessions to increase probability of appropriate and completed referrals, and incentives (such as phone cards, public transportation tokens, waist wallets, grooming and sanitary supplies) for service engagement. Clients assigned to the control condition are given the opportunity to see the social worker but they are not directly referred at the time that they visit the van. Thus controls are self-referred to the social worker; they are also not given incentives for repeated sessions. Preliminary data with the first 128 subjects enrolled in the study shows that ICM clients compared to controls had more contacts with the social worker (5.8 vs. 1.4) and received (1.29 vs. 0.58) and completed (0.92 vs. 0.36) more referrals. Four-month outcomes (80% follow-up) show that all study subjects, regardless of condition, reported past 30 day reductions in crack use (4.1 vs. 2.2 days), days homeless (13.2 vs. 10.2), and number of health complaints (6.3 vs. 4.8). Effects for ICM, compared with the control conditions, were found for the receipt or maintenance of public assistance (e.g., Medical insurance [Medicaid] and Food Stamps) (72% vs. 50%), and for fewer hospital emergency rooms visits (26% vs. 45%). All above comparisons were statistically significant (p <:05). CONCLUSION The van operates with a clientele with high levels of homelessness, substance use, and infectious diseases. Reductions in drug use, homelessness, and physical symptoms may represent the benefit from the medical encounter all subjects received on the van. The incorporation of ICM, which included the immediate availability of on-site case management services in conjunction with the ongoing van operation, appears to provide an added benefit of engaging highly impaired individuals and helping them to acquire and maintain publicassistance benefits. The mobile medical outreach appears to provide a good opportunity for identifying serious communicable diseases, HIV counseling, and primary care treatment.

4 1272 ROSENBLUM ET AL. ACKNOWLEDGMENT Study funded by NIDA RO1 DA REFERENCES 1. Edlin, B.R.; Irwin, K.L.; Faruque, S.; McCoy, C.B.; Word, C.; Serrano, Y.; Inciardi, J.A.; Bowser, B.P.; Schilling, R.F.; Holmberg, S.D. The Multicenter Crack Cocaine and HIV Infection Study Team. Intersecting Epidemics Crack Cocaine Use and HIV Infection Among Inner-City Young Adults. N. Engl. J. Med. 1994, 331 (21), Novick, D.; Joseph, H. et al. Absence of HIV Antibodies in Rehabilitated Methadone Patients. Arch. Internal Med. 1990, 150, Centers for Disease Control (CDC). Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-related ChronicDisease. MMWR 1998, 47 (Suppl.), Wright, J.D. The Health of Homeless People: Evidence from the National Health Care for the Homeless Program. In Under the Safety Net; Brickner, P.W., Scharer, K.L., Conanan, B.A., Savarese, M., Scanlan, B.C., Eds.; W.W. Norton: New York, Brickner, P.W.; McAdam, J.M.; Torres, R.A.; Vicic, W.J.; Conanan, B.A.; Detrano, T.; Piantieri, O.; Scanlan, B.; Scharer, L.K. Providing Health Services for the Homeless: A Stitch in Time. N.Y. Acad. Med. 1993, 70 (3): THE AUTHORS Andrew Rosenblum, Ph.D., is the Deputy Executive Director of the National Development and Research Institutes, Inc. He has served as principle investigator, co-investigator and project director on several research projects on substance use, including innovative interventions for the treatment of cocaine dependence, outreach to homeless populations, and an evaluation of a treatment linkage model for street-based sex workers. Larry Nuttbrock is currently a Project Director with the National Development and Research Institutes (NDRI). His recent work includes an evaluation of alternative treatment modalities for homeless mentally-ill chemical abusers, an assessment of mobile medical outreach to homeless

5 OUTREACH TO HOMELESS SUBSTANCE USERS 1273 people, and an analysis of the association between cocaine use and HIV infection among soup kitchen attendees in New York City. Hunter L. McQuistion, M.D., is Medical Director of Project Renewal, Inc., New York City s leading nonprofit organization serving disabled adult homeless people. He teaches and publishes widely, and is an Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine. Dr. McQuistion sub-specializes in community psychiatry, and has special interests in techniques of engaging difficult to reach clinical populations and in accessing indigent communities to integrated systems of health and social services. He is also Treasurer of the American Association of Community Psychiatrists and is a Fellow of the American Psychiatric Association. Stephen Magura, Ph.D., C.S.W., is Director of the Institute for Treatment and Services Researches at National Development and Research Institutes, Inc. He has designed and directed clinical trials, treatment outcome studies, health services research, social epidemiology studies, HIV prevention research, and policy analysis, as related to drug dependency. He has published over 100 articles and authored/edited several books and special journal issues on outcome evaluation and clinical trials, including Experimental Therapeutics in Addiction Medicine. Herman Joseph, Ph.D., is a Senior Research Scientist at the New York State Office of Alcohol and Substance Abuse Services (OASAS). He has played a pivotal role in substance abuse treatment research in New York City. Along with Dr. Vincent Dole, he conducted one of the first follow-up studies that documented the benefits of methadone maintenance for the treatment of opiate dependence. He is founder and chairperson of the Chemical Dependency Research Working Group and is founder and executive chair of the International Substance Abuse and Pain Conference. His seminal publications have addressed AIDS and hepatitis C among homeless IV drug users, treatment of IVDUs in the criminal justice system, and methadone medical maintenance.

6

7

8

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders CURRICULUM VITAE H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director, Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration Department of Health & Human Services

More information

TREATMENT MODALITIES. May, 2013

TREATMENT MODALITIES. May, 2013 TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.

More information

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral

More information

DIVISION of SUBSTANCE ABUSE SERVICES. Tuberculosis Control Guidelines for Alcohol and Drug Abuse Treatment Programs

DIVISION of SUBSTANCE ABUSE SERVICES. Tuberculosis Control Guidelines for Alcohol and Drug Abuse Treatment Programs DIVISION of SUBSTANCE ABUSE SERVICES Tuberculosis Control Guidelines for Alcohol and Drug Abuse Treatment Programs 1. Purpose: This policy provides guidance and instruction to identify and prevent tuberculosis

More information

Health Care for the Homeless. Comprehensive Services to Meet Complex Needs

Health Care for the Homeless. Comprehensive Services to Meet Complex Needs Health Care for the Homeless Comprehensive Services to Meet Complex Needs Health Care for the Homeless Comprehensive Services to Meet Complex Needs Serious personal health problems and flaws in health

More information

Challenges to Hepatitis C Virus (HCV) Care via Telemedicine for Individuals on Opiate Agonist Therapy

Challenges to Hepatitis C Virus (HCV) Care via Telemedicine for Individuals on Opiate Agonist Therapy Challenges to Hepatitis C Virus (HCV) Care via Telemedicine for Individuals on Opiate Agonist Therapy Andrew Talal, MD, MPH 1 Marija Zeremski, PhD 2 Roberto Zavala, MD 3 Rositsa Dimova, PhD 1 Melissa Lin,

More information

Does referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol

Does referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol Does referral from an emergency department to an alcohol treatment center reduce subsequent emergency room visits in patients with alcohol intoxication? Robert Sapien, MD Department of Emergency Medicine

More information

Poverty, Gender Inequality and HIV: Understanding Sex Workers Dilemma and Health

Poverty, Gender Inequality and HIV: Understanding Sex Workers Dilemma and Health Poverty, Gender Inequality and HIV: Understanding Sex Workers Dilemma and Health Wendee M. Wechsberg, Ph.D. RTI International University of North Carolina, School of Public Health, Duke University School

More information

Treatment of Prescription Opioid Dependence

Treatment of Prescription Opioid Dependence Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription

More information

Overview of Chemical Addictions Treatment. Psychology 470. Background

Overview of Chemical Addictions Treatment. Psychology 470. Background Overview of Chemical Addictions Treatment Psychology 470 Introduction to Chemical Additions Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides 1 Background Treatment approaches

More information

Perceptions and Use of Medical Marijuana in an Urban Substance Treatment Program

Perceptions and Use of Medical Marijuana in an Urban Substance Treatment Program Perceptions and Use of Medical Marijuana in an Urban Substance Treatment Program Corresponding Author: Charles Shuman M.D. Denver Health and Hospital Authority and the University of Colorado Denver, 667

More information

Testimony of The New York City Department of Health and Mental Hygiene. before the

Testimony of The New York City Department of Health and Mental Hygiene. before the Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid

More information

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System. New Jersey Substance Abuse Monitoring System The NJSAMS Report May 2011 Admissions to Substance Abuse Treatment in New Jersey eroin is a semi-synthetic opioid drug derived from morphine. It has a high

More information

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

HPTN 073: Black MSM Open-Label PrEP Demonstration Project HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers

More information

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Strategies to Improve the HCV Continuum of Care:

Strategies to Improve the HCV Continuum of Care: Strategies to Improve the HCV Continuum of Care: Best Practices in Testing, Linkage to Care & Treatment Ronald O. Valdiserri, M.D., M.P.H. Deputy Assistant Secretary for Health, Infectious Diseases June

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

Hepatitis Services in Substance Abuse Treatment Settings

Hepatitis Services in Substance Abuse Treatment Settings Hepatitis Services in Substance Abuse Treatment Settings Funding provided by the Center for Substance Abuse Treatment The Matrix Institute Dan George Overview Hx of HCV group s implementation at OTP clinic

More information

METHADONE SUBSTITUTION THERAPY PROGRAM AND TOXICOLOGICAL STUDIES

METHADONE SUBSTITUTION THERAPY PROGRAM AND TOXICOLOGICAL STUDIES METHADONE SUBSTITUTION THERAPY PROGRAM AND TOXICOLOGICAL STUDIES Halina MATSUMOTO, El bieta WO NY, Anna DZIKLIÑSKA, Ma³gorzata ABRAMOWSKA Laboratory of Psychopharmacology, 1st Department of Psychiatry,

More information

Substance Abuse Treatment Evaluations and Interventions Program

Substance Abuse Treatment Evaluations and Interventions Program Substance Abuse Treatment Evaluations and Interventions Program Project Highlights: HIV Interventions in North Carolina Wendee Wechsberg, Ph.D. SATEI Program Director RTI International 3040 Cornwallis

More information

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

MENTAL ILLNESS AND SUBSTANCE ABUSE

MENTAL ILLNESS AND SUBSTANCE ABUSE MENTAL ILLNESS AND SUBSTANCE ABUSE PROBLEM What is the problem for Dallas County? Individuals with co-existing conditions of mental illness and substance abuse are a great burden on the mental health system,

More information

Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting

Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner NASADAD 2015 Annual Meeting Background Goal of Health Care Reform Triple Aim: Better Population

More information

HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting

HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting Takako Schaninger, MD Program Director Southern Central AIDS Education Telehealth Training

More information

MONROE COUNTY OFFICE OF MENTAL HEALTH, DEPARTMENT OF HUMAN SERVICES RECOVERY CONNECTION PROJECT PROGRAM EVALUATION DECEMBER 2010

MONROE COUNTY OFFICE OF MENTAL HEALTH, DEPARTMENT OF HUMAN SERVICES RECOVERY CONNECTION PROJECT PROGRAM EVALUATION DECEMBER 2010 MONROE COUNTY OFFICE OF MENTAL HEALTH, DEPARTMENT OF HUMAN SERVICES RECOVERY CONNECTION PROJECT PROGRAM EVALUATION DECEMBER 2010 Prepared For: Kathleen Plum, RN, PhD Director, Monroe County Office of Mental

More information

Bringing Hepatitis C Treatment into the Medical Home

Bringing Hepatitis C Treatment into the Medical Home Bringing Hepatitis C Treatment into the Medical Home Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission Neighborhood Health Center, San Francisco, CA The Challenge: Hepatitis C Virus

More information

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective

More information

Office ID Location: City State Date / / PRIMARY CARE SURVEY

Office ID Location: City State Date / / PRIMARY CARE SURVEY A. Organizational Characteristics PRIMARY CARE SURVEY We want to learn more about the general features of your office. A1. What health-related services does your office provide (check all that apply)?

More information

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014 Outcomes for Opiate Users at FRN Facilities FRN Research Report September 2014 Introduction The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al,

More information

Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4

Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4 Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) This document seeks to name the criteria that can guide referrals to residential tier 4 facilities (Part A). It provides guidance

More information

The Changing Face of Opioid Addiction:

The Changing Face of Opioid Addiction: 9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept

More information

Health Care Law School Attitudes and Beliefs About Buprenorphine

Health Care Law School Attitudes and Beliefs About Buprenorphine 336 May 2006 Family Medicine Clinical Research and Methods Attending Physicians and Residents Attitudes and Beliefs About Prescribing Buprenorphine at an Urban Teaching Hospital Chinazo O. Cunningham,

More information

Linking female sex workers with substance abuse treatment

Linking female sex workers with substance abuse treatment Journal of Substance Abuse Treatment 27 (2004) 233 239 Linking female sex workers with substance abuse treatment Larry A. Nuttbrock, (Ph.D.) a, *, Andrew Rosenblum, (Ph.D.) a, Stephen Magura, (Ph.D.) a,

More information

Strengthening the HCV Continuum of Care

Strengthening the HCV Continuum of Care Strengthening the HCV Continuum of Care Fabienne Laraque, MD, MPH, Medical Director Viral Hepatitis Surveillance, Prevention and Control Bureau of Communicable Diseases Control, NYC DOHMH March 18, 2014

More information

Lost in Translation: The use of in-person interpretation vs. telephone interpretation services in the clinic setting with Spanish speaking patients

Lost in Translation: The use of in-person interpretation vs. telephone interpretation services in the clinic setting with Spanish speaking patients Kellie Hawkins, MD, MPH CRC IRB Proposal November 2011 Lost in Translation: The use of in-person interpretation vs. telephone interpretation services in the clinic setting with Spanish speaking patients

More information

CASE STUDY: SPECIAL HEALTH RESOURCES OF EAST TEXAS Longview, Texas

CASE STUDY: SPECIAL HEALTH RESOURCES OF EAST TEXAS Longview, Texas CASE STUDY: SPECIAL HEALTH RESOURCES OF EAST TEXAS Longview, Texas This project was funded by a grant from the Health Resources and Services Administration, U.S. Department of Health and Human Services,

More information

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW 1 THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW By Dr. Des Crowley, General Practitioner INTRODUCTION The Drug Detox Unit was opened in July 1996 at Mountjoy Prison in response to the escalating drug

More information

Transitional Grant Area (TGA) Definition

Transitional Grant Area (TGA) Definition S OF CARE Oakland Transitional Grant Area Care and Treatment Services O CTOBER 2006 Office of AIDS Administration 1000 Broadway, Suite 310 Oakland, CA 94607 Tel: 510.268.7630 Fax: 510.268.7631 AREAS OF

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Expanding access to treatment for opiate addiction: Successes and Barriers

Expanding access to treatment for opiate addiction: Successes and Barriers Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise Lodge Addiction Treatment Hospital, NM Department of Health; and UNM Project ECHO

More information

Claudia A. Zsigmond, Psy.D. FL. License # PY7297

Claudia A. Zsigmond, Psy.D. FL. License # PY7297 Claudia A. Zsigmond, Psy.D. FL. License # PY7297 EDUCATION 9/1989- State University of New York at Buffalo, Buffalo, NY 6/1993 Bachelor of Arts, Psychology, cum laude 9/1995- Illinois School of Professional

More information

LTBI Program Implementation in a Substance Abuse Treatment Facility

LTBI Program Implementation in a Substance Abuse Treatment Facility LTBI Program Implementation in a Substance Abuse Treatment Facility (A Case Study) Acknowledgments The New Jersey Medical School (NJMS) National Tuberculosis Center wishes to acknowledge the following

More information

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636) Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call

More information

The Maryland Public Behavioral Health System

The Maryland Public Behavioral Health System The Maryland Public Behavioral Health System Arleen Rogan, Ph.D. Division Director, Integrated Health Services Family Services, Inc. Arleen.rogan@fs-inc.org Behavioral Health includes: Mental health conditions

More information

PARTICIPANT ORIENTATION COURSE

PARTICIPANT ORIENTATION COURSE a monitoring and recovery program for nurses PARTICIPANT ORIENTATION COURSE C R E AT E D B Y R O B I N A. L E W I S, E d D, M S N, F N P - B C, R N R E V I S E D B Y S A N D R A H U D S O N, R N, B S N,

More information

Re-Considering Addiction Treatment. Have We Been Thinking Correctly?

Re-Considering Addiction Treatment. Have We Been Thinking Correctly? Re-Considering Addiction Treatment Have We Been Thinking Correctly? Part I FDA standards of effectiveness Do substance abuse treatments meet those standards? An FDA Perspective A Drug is Approved for An

More information

CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12

CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12 Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

UNIVERSITY OF MIAMI Curriculum Vitae

UNIVERSITY OF MIAMI Curriculum Vitae UNIVERSITY OF MIAMI Curriculum Vitae DATE: June 8, 2004 PERSONAL Name: Kathryn Estelle McCollister Home Phone: (305) 673-2449 Office Phone: (305) 243-3479 Home Address: 725 14 Place, Apt. 8, Miami Beach,

More information

Policy Rationale and Text

Policy Rationale and Text Policy Title: Impaired Resident Physicians Original Date: July 2010 GMEC Endorsed: April 2015 Next Revision Date: April 2017 David C. Weigle, PhD, MPH Assistant Dean for Graduate Medical Education Designated

More information

Memphis TGA Ryan White Part A & MAI Substance Abuse-Outpatient Standards of Care

Memphis TGA Ryan White Part A & MAI Substance Abuse-Outpatient Standards of Care PURPOSE Memphis TGA Ryan White Part A & MAI Substance Abuse-Outpatient The purpose of the Ryan White Part A and MAI Substance Abuse- Outpatient is to ensure that uniformity of service exists in the Memphis

More information

Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework

Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework Benedikt Fischer, PhD Professor, CIHR/PHAC Chair in Applied Public Health & MSFHR Senior Scholar Faculty

More information

Hepatitis C Infections in Oregon September 2014

Hepatitis C Infections in Oregon September 2014 Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with

More information

WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider.

WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider. WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider. Our highly trained and dedicated team of counselors and physicians

More information

Therapeutic Community Treatment: Special Populations and Special Settings

Therapeutic Community Treatment: Special Populations and Special Settings Therapeutic Community Treatment: Special Populations and Special Settings ATCA Conference Byron Bay, Australia, September 2008 George De Leon Center for Therapeutic Community Research at NDRI, Inc. New

More information

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency A Ministry of the Archdiocese of Galveston-Houston A United Way Agency Integrated Multidsciplinary Approach to Adapt Routine HIV Screening in a Safety Net Clinic Setting Sherri D. Onyiego MD, PhD Baylor

More information

A Family-Based Substance Abuse, Delinquency and HIV Prevention Intervention for Detained Adolescents

A Family-Based Substance Abuse, Delinquency and HIV Prevention Intervention for Detained Adolescents A Family-Based Substance Abuse, Delinquency and HIV Prevention Intervention for Detained Adolescents CRAIG HENDERSON a, GAYLE DAKOF b, CINDY ROWE b CINDY MENA a, HYEMIN JEON a, SCHOLAR COLBOURN a, & HOWARD

More information

An Electronic Health Record Alert for Hepatitis C Screening of Baby Boomers in Primary Care: A Cluster Randomized Controlled Trial

An Electronic Health Record Alert for Hepatitis C Screening of Baby Boomers in Primary Care: A Cluster Randomized Controlled Trial An Electronic Health Record Alert for Hepatitis C Screening of Baby Boomers in Primary Care: A Cluster Randomized Controlled Trial K Krauskopf, N Kil, A Sofianou, W Toribio, J Lyons, M Singer, J Kannry,

More information

Rates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs

Rates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs Rates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs Nicole M. Capezza, Ph.D. Lisa M. Najavits, Ph.D. Objective: Trauma-informed treatment increasingly

More information

Fairfax-Falls Church Community Services Board

Fairfax-Falls Church Community Services Board LOB #267: ADULT RESIDENTIAL TREATMENT SERVICES Purpose Adult Residential Treatment Services provides residential treatment programs for adults with severe substance use disorders and/or co occurring mental

More information

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons. Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize

More information

Putting Addiction Treatment Medications to Use: Lessons Learned

Putting Addiction Treatment Medications to Use: Lessons Learned Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)

More information

Integrating Viral Hepatitis Counseling and testing in Substance Abuse Programs. By Barbara Rush CAAPP2 The Center For Drug Free Living Inc.

Integrating Viral Hepatitis Counseling and testing in Substance Abuse Programs. By Barbara Rush CAAPP2 The Center For Drug Free Living Inc. Integrating Viral Hepatitis Counseling and testing in Substance Abuse Programs By Barbara Rush CAAPP2 The Center For Drug Free Living Inc. Why Integrate Hepatitis in Substance Abuse Programs? Substance

More information

Various therapies are used in the

Various therapies are used in the National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Overview of Opioid Treatment Programs within the United States: 2008 In Brief In 2008, a total of 1,132 (8 of all

More information

THE SUBSTANCE ABUSE TREATMENT SYSTEM: WHAT DOES IT LOOK LIKE AND WHOM DOES IT SERVE?

THE SUBSTANCE ABUSE TREATMENT SYSTEM: WHAT DOES IT LOOK LIKE AND WHOM DOES IT SERVE? E THE SUBSTANCE ABUSE TREATMENT SYSTEM: WHAT DOES IT LOOK LIKE AND WHOM DOES IT SERVE? Preliminary Findings from the Alcohol and Drug Services Study Constance M. Horgan and Helen J. Levine Institute for

More information

TEXAS HIV CONNECTION: OUR COURSES

TEXAS HIV CONNECTION: OUR COURSES Texas HIV Connection 1 TEXAS HIV CONNECTION: OUR COURSES Generally, courses offered by the Texas HIV Connection: meet DSHS licensure and funding requirements provide professional continuing education credits

More information

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA Stefan R. Rowniak, PhD, RN, MS, FNP EDUCATION 2010 2010 1991 1985 1979 1976 SF State University Seattle University Seattle, WA University of Washington Seattle, WA Post-Doctoral Student PhD, Nursing MSN,

More information

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule

More information

Topics In Addictions and Mental Health: Concurrent disorders and Community resources. Laurence Bosley, MD, FRCPC

Topics In Addictions and Mental Health: Concurrent disorders and Community resources. Laurence Bosley, MD, FRCPC Topics In Addictions and Mental Health: Concurrent disorders and Community resources Laurence Bosley, MD, FRCPC Overview Understanding concurrent disorders. Developing approaches to treatment Definitions

More information

CASE STUDY: CHICAGO HEALTH OUTREACH Chicago, Illinois

CASE STUDY: CHICAGO HEALTH OUTREACH Chicago, Illinois CASE STUDY: CHICAGO HEALTH OUTREACH Chicago, Illinois This project was funded by a grant from the Health Resources and Services Administration, U.S. Department of Health and Human Services, grant #4H97HA001580201.

More information

Prison and Jail Health January 18, 2007. Viewer Call-In. Evaluations. www.t2b2.org. Phone: 800-452-0662 Fax: 518-426-0696. 518-402-0330 www.t2b2.

Prison and Jail Health January 18, 2007. Viewer Call-In. Evaluations. www.t2b2.org. Phone: 800-452-0662 Fax: 518-426-0696. 518-402-0330 www.t2b2. Prison and Jail Health January 18, 2007 Guthrie S. Birkhead, M.D., M.P.H Director, AIDS Institute and Center for Community Health New York State Department of Health (NYSDOH) Lester N. Wright, M.D., M.P.H.

More information

CONTINGENCY MANAGEMENT AND ANTISOCIAL PERSONALITY DISORDER

CONTINGENCY MANAGEMENT AND ANTISOCIAL PERSONALITY DISORDER CONTINGENCY MANAGEMENT AND ANTISOCIAL PERSONALITY DISORDER Karen K. Chan 1,3, Alice Huber 1,2,3, John M. Roll 1,3, and Vikas Gulati 1,3 Friends Research Institute, Inc. 1 Long Beach Research Foundation:

More information

Title 10 DEPARTMENT OF HEALTH AND MENTAL HYGIENE

Title 10 DEPARTMENT OF HEALTH AND MENTAL HYGIENE Title 10 DEPARTMENT OF HEALTH AND MENTAL HYGIENE Subtitle 21 MENTAL HYGIENE REGULATIONS Chapter 26 Community Mental Health Programs Residential Crisis Services Authority: Health-General Article, 10-901

More information

Testimony Department of Human Services Commission on Alternatives to Incarceration Representative, Lisa Wolf, Chairman March 24, 2010

Testimony Department of Human Services Commission on Alternatives to Incarceration Representative, Lisa Wolf, Chairman March 24, 2010 Testimony Department of Human Services Commission on Alternatives to Incarceration Representative, Lisa Wolf, Chairman March 24, 2010 Chairman Wolf and members of the Commission on Alternatives to Incarceration,

More information

Project AWARE Study Overview. Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD

Project AWARE Study Overview. Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD Project AWARE Study Overview Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD January 9, 2012 Two Testing Strategies Evaluated in 2-arm RCT On-site HIV rapid testing (via fingerstick) with brief participant-tailored

More information

ASSERTIVE COMMUNITY TREATMENT: ACT 101. Rebecca K. Sartor, LICSW

ASSERTIVE COMMUNITY TREATMENT: ACT 101. Rebecca K. Sartor, LICSW ASSERTIVE COMMUNITY TREATMENT: ACT 101 Rebecca K. Sartor, LICSW A LITTLE BIT ABOUT ME HOW I ENDED UP HERE LEARNING OBJECTIVES To develop an understanding of: How ACT Evolved Practice Principles Services

More information

The use of alcohol and drugs and HIV treatment compliance in Brazil

The use of alcohol and drugs and HIV treatment compliance in Brazil The use of alcohol and drugs and HIV treatment compliance in Brazil André Malbergier, MD, PhD Hospital das Clínicas Medical School University of São Paulo Brasil The Casa da AIDS offers specialized integral

More information

Designing Clinical Addiction Research

Designing Clinical Addiction Research Designing Clinical Addiction Research Richard Saitz MD, MPH, FACP, FASAM Professor of Medicine & Epidemiology Boston University Schools of Medicine & Public Health Director, Clinical Addiction, Research

More information

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

More information

Critical Time Intervention in North Carolina. Barbara B. Smith, MSW, LCSW Clinical Assistant Professor UNC School of Social Work

Critical Time Intervention in North Carolina. Barbara B. Smith, MSW, LCSW Clinical Assistant Professor UNC School of Social Work Critical Time Intervention in North Carolina Barbara B. Smith, MSW, LCSW Clinical Assistant Professor UNC School of Social Work Critical Time Intervention: Local Pilot and Statewide Championing is funded

More information

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts

More information

SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE

SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE By: Christine Kim Cal State University, Long Beach May 2014 INTRODUCTION Substance use among

More information

Maryland Data as of July 2003. Mental Health and Substance Abuse Services in Medicaid and SCHIP in Maryland

Maryland Data as of July 2003. Mental Health and Substance Abuse Services in Medicaid and SCHIP in Maryland Mental Health and Substance Abuse Services in Medicaid and SCHIP in Maryland As of July 2003, 638,662 people were covered under Maryland's Medicaid/SCHIP programs. There were 525,080 enrolled in the Medicaid

More information

Beyond the Revolving Door

Beyond the Revolving Door Advancing community health through California s open door providers Beyond the Revolving Door California s Open Door Providers Address the Needs of Frequent Users of Medical Services 2002 California Health

More information

Substance Abuse Treatment Admissions for Abuse of Benzodiazepines

Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Treatment Episode Data Set The TEDS Report June 2, 2011 Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Benzodiazepines are a class of central nervous system depressant drugs that are

More information

Substance Abuse Treatment Services Policy

Substance Abuse Treatment Services Policy Substance Abuse Treatment Services Policy Rhode Island Department of Children, Youth and Families Policy: 700.0195 Effective Date: June 1, 2000 Version: 1 The Department frequently works with families

More information

CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES

CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES GENERAL PROVISIONS Sec. 1223.1. Policy. 1223.2. Definitions. 1223.11. Types of services covered. 1223.12. Outpatient services. 1223.13. Inpatient

More information

Clinical Priorities for Alcohol and Drugs in Public Health

Clinical Priorities for Alcohol and Drugs in Public Health Clinical Priorities for Alcohol and Drugs in Public Health What do we need to Measure up to? Dr Michael Kelleher Clinical Lead Alcohol and Drugs Team, Health and Wellbeing Directorate SMMGP 8 th Primary

More information

Prescription Opioid Overdose & Misuse in Oregon

Prescription Opioid Overdose & Misuse in Oregon Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing

More information

ESTIMATING SUBSTANCE ABUSE TREATMENT NEED FROM THE NHSDA

ESTIMATING SUBSTANCE ABUSE TREATMENT NEED FROM THE NHSDA ESTIMATING SUBSTANCE ABUSE TREATMENT NEED FROM THE NHSDA Joan F. Epstein, and Joseph C. Gfroerer, Substance Abuse and Mental Health Services Administration Joan F. Epstein, 5600 Fishers Lane, Room 16C-06,

More information

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence

More information

Screening and Brief Intervention for Unhealthy Alcohol and Other Drug Use in Primary Care

Screening and Brief Intervention for Unhealthy Alcohol and Other Drug Use in Primary Care Screening and Brief Intervention for Unhealthy Alcohol and Other Drug Use in Primary Care Richard Saitz MD MPH FACP FASAM Professor of Medicine & Epidemiology Clinical Addiction Research and Education

More information

CHEMICAL DEPENDENCE INPATIENT REHABILITATION SERVICES. [Statutory Authority: Mental Hygiene Law Sections 19.07(e), 19.09(b), 19.40, 32.01, 32.

CHEMICAL DEPENDENCE INPATIENT REHABILITATION SERVICES. [Statutory Authority: Mental Hygiene Law Sections 19.07(e), 19.09(b), 19.40, 32.01, 32. PART 818 CHEMICAL DEPENDENCE INPATIENT REHABILITATION SERVICES [Statutory Authority: Mental Hygiene Law Sections 19.07(e), 19.09(b), 19.40, 32.01, 32.07(a)] Notice: The following regulations are provided

More information

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate

More information